Abstract
Cell migration and invasion requires the precise temporal and spatial orchestration of a variety of biological processes. Filaments of polymerized actin are critical players in these diverse processes, including the regulation of cell anchorage points (both cell-cell and cell-extracellular matrix), the uptake and delivery of molecules via endocytic pathways and the generation of force for both membrane protrusion and retraction. How the actin filaments are specialized for each of these discrete functions is yet to be comprehensively elucidated. The cytoskeletal tropomyosins are a family of actin associating proteins that form head-to-tail polymers which lay in the major groove of polymerized actin filaments. In the present review we summarize the emerging isoform-specific functions of tropomyosins in cell migration and invasion and discuss their potential roles in the specialization of actin filaments for the diverse cellular processes that together regulate cell migration and invasion.
Key words: tropomyosin, actin, migration, invasion, cytoskeleton, actin dynamics, adhesion
Actin is the most abundant protein in eukaryotic cells and is critical for maintaining structural integrity. The polymerization of globular (G)-actin monomers forms actin filaments (F-actin),1 which play a role in diverse and complex cellular functions including intercellular transport of organelles and vesicles,2,3 cytokinesis,4 apoptosis5 and cell motility.6 Intricate details describing the molecular scale interactions between regulatory proteins and actin have been extensively investigated but the mechanistic control of diverse actin filament functions remain largely unclear. Recent improvements in analysis techniques7 and the use of physiologically relevant models of 3D cell culturing8 have now begun to reveal mechanisms of actin cytoskeleton regulation. Accruing evidence suggests that the actin decorating protein tropomyosin is a key regulator of actin filament specialization. Of particular interest is the impact that tropomyosin regulation has on actin filament activity during cell migration and invasion that underpins immunological cell homing, development, wound healing and metastasis.
A Diverse Palette of Tropomyosins
Tropomyosins are highly abundant proteins found in virtually all life-forms except plants and bacteria.9 Two essential and non-redundant tropomyosin isoforms encoded by separate genes are present in the yeast Saccharomyces cerevisiae.10 The pattern is considerably more complex in vertebrates, with the human genome containing four separate tropomyosin genes: TPM1 (or α-tropomoysin), TPM2 (or β-tropomyosin), TPM3 (or γ-tropomyosin) and TPM4 (or δ-tropomyosin).11 The presence of the same four tropomyosin genes in other vertebrate species, including chickens, indicates that divergence of this gene family took place more than 300 million years ago prior to the separation of birds and mammals.11 Multiple promoters and alternative splicing of up to 15 exons enables the production of at least 40 different tropomyosin isoforms,12 recently comprehensively reviewed in reference 9. Based on their molecular mass, tropomyosins are conventionally referred to as either high (HMW: ∼284 amino acids) or low (LMW: ∼248 amino acids) molecular weight; however both LMW and HMW isoforms can be expressed from the same gene.13 The failure to produce viable embryos following homozygous deletion of specific exons from the TPM3 gene,14 suggests that these proteins have non-redundant functions.
Tropomyosin Decoration of Actin Filaments
Tropomyosin molecules form dimers containing partially repeated actin binding sequences.15 When associated with actin, tropomyosin forms a coiled polymer in which dimers of tropomyosin associate head to tail and lie in the major groove of the actin filament16 (Fig. 1). The coil is characterized by a heptapeptide amino acid repeat sequence common to all α-helices with the consensus motif -B-N-X-X-N-A-X-, where N indicates non-polar residues, B indicates basic residues and A signifies acidic residues.16,17 Hydrophobic interactions within the coil core and interaction between side chains of amino acids situated in close proximity maintain the stability of the coiled coil. Variability in the positioning of particular amino acid residues at key binding sites is thought to impact the flexibility of the tropomyosin polymer, thereby affecting its ability to interact with F-actin.17,18 Heterodimerization can occur between tropomyosin isoforms from separate genes;19 for example, heterodimerization between α-skeletal muscle isoforms from the TPM1 gene and β-skeletal muscle isoforms from the TPM2 gene are required to maintain healthy skeletal muscle function.20 Other heterodimer configurations include heterodimerization of LMW isoforms from the TPM3 gene (such as Tm5NM1) with the LMW TPM1 isoforms Tm5a and Tm5b,21 thus indicating the functional importance of the heterodimer combinations. HMW and LMW tropomyosin isoforms, however, do not combine to form stable dimers.21 The formation of heterodimers also increases the number of different tropomyosin dimers, which may achieve the structural complexity or flexibility necessary for distinct regulation on actin dynamics.
Figure 1.
Tropomyosin decoration of an actin filament. Cartoon depicting tropomyosin lying in the major groove of an actin filament. Shown in the top expanded box are binding partners of muscle actin including the troponin complex, a calcium ion and a dimer of myosin II (the tail region extending to the thick muscle filament is not shown). The bottom box shows cytoskeletal actin associating with tropomyosin and non-muscle myosin II (the tail region extending to bind to other non-muscle myosin II dimer tail regions is not shown).
Having first been discovered in muscle tissue, tropomyosin was originally considered to have muscle-specific function. Subsequent demonstrations of a wider diversity of the so-called “cytoskeletal” tropomyosins in non-muscle cells dispelled this idea. While general principles of tropomyosin function established in muscle cells are held to be true in non-muscle cells, it is important to use some caution when basing mechanisms on such assumptions, given the highly specialized nature of the contractile actin skeleton in muscle. The tropomyosin name derived from shared chemical and physical properties with myosin, including its solubility, large angle X-ray pattern type and absolute amounts of many amino acids. At the time the protein was described in 1948 these analysis techniques were the best available and tropomyosin was initially incorrectly thought to be either a precursor of myosin or a unit of the myosin polymer.22 Tropomyosin's role in skeletal muscle contraction, where it interacts with actin, myosin II and the troponin complex (Fig. 1), has been the subject of extensive investigation.16,23 The thin muscle fibers comprise skeletal tropomyosin in a coiled-coil around actin filament and bound to the troponin complex. The thick muscle fiber is made of multiple myosin II chains that are activated upon binding to actin, creating mechanical activity via an ATP driven power stroke and muscle contraction. Electrical stimulation of Ca2+ channels promotes the binding of troponin C to Ca2+, shifting the troponin C binding position relative to tropomyosin, in turn altering tropomyosin binding to the actin filament. The movement of the tropomyosin coiled coil unmasks the myosin II binding site allowing actomyosin contraction to take place.24 Repositioning of the tropomyosin coiled coil in the major groove of the actin filament and consequent regulation of myosin association is thought to be a primary mechanism for tropomyosin determination of actin dynamics.25
In contrast to the stable actin structures controlling muscle contraction, the actin filament system in migrating non-muscle cells is highly dynamic, allowing for rapid and responsive reorganization. Tropomyosins are proposed to contribute to the dynamic state of the actin cytoskeleton by imparting isoform-specific inhibitions of critical actin filament regulators. Current knowledge regarding the effects of individual cytoskeletal tropomyosin isoforms is summarized in Table 1. Certain tropomyosin isoforms compete with or recruit ADF/cofilin binding to F-actin,26–30 while others anneal actin filaments that are severed and capped by gelosin31,32 and can inhibit the branching and actin polymerization activity of Arp2/3 in vitro.33,34 Different tropomyosin isoforms compete with actin bundling proteins,35 and can also coordinate with caldesmon to inhibit the activity of fascin.36 In contrast, in fission yeast the actin bundling protein fimbrin dissociates tropomyosin from actin filaments, promoting access for ADF/cofilin and potentially other actin regulating proteins.37 Recent data suggest that the association of discrete isoforms with actin filaments can determine the sensitivity to actin depolymerizing drugs such as latrunculin.38 Thus, contrary to the previously held view that tropomyosins universally stablize the actin filament, it is now becoming appreciated these proteins can either increase or decrease the filament stability depending on the associated tropomyosin isoform.
Table 1.
Effect of individual cytoskeletal tropomyosin isoforms on actin filament dynamics
Isoform | Effect on actin filaments | Proposed Mode of action | Reference |
Tm5NM1 | Increased filament resistance to actin-depolymerizing drugs | Increased recruitment and activation of myosin II and exclusion of ADF/cofilin*, suggested to stabilize associated actin filaments | 9, 28, 38, 59 |
Tm3 | Increased filament sensitivity to actin-depolymerizing drugs | Increased recruitment of ADF/cofilin to the filament | 30, 38, 59 |
TmBr3 | Reduced actin stress fibre formation | Reduced myosin activity | 28, 60 |
Tm5a | Inhibits Arp2/3 mediated branching in vitro | May compete with Arp2/3 for binding to filament# | 33^ |
Tm2 | Inhibits Arp2/3 mediated branching in vitro (effects are less than Tm5a) | May compete with Arp2/3 for binding to filament# | 33^ |
Only studies in which individual isoforms have been investigated are included, other studies reporting effects on filament annealing, severing and competition for other actin-binding proteins have been carried out using a mix of Tm isoforms,31,32,35,36 thus preventing assignment of isoform-specific roles.
Studies of muscle tropomyosin isoforms demonstrate competition between tropomyosin and ADF for actin filament binding.26,27,29
Blanchoin et al. make the important point that saturating concentrations of Tms did not result in complete Arp2/3 inhibition and the relative abilities of the Tm isoforms to block Arp2/3 inhibition does not correlate with their affinities for actin, thus suggesting that the mode of action may be more than simple binding of Tm to the actin filaments.33
Skeletal muscle tropomyosin has been shown to compete with Arp2/3 for binding to actin filaments in vitro.34
Tropomyosins also bind to members of the tropomodulin protein family at the pointed end of actin filaments and affect cytoskeletal dynamics within both muscle and non-muscle cells. Coordinated activity between tropomyosin and tropomodulin thus decreases the rate of depolymerization at the pointed end, which leads to stabilization of the actin filament.39 The effectiveness of this pointed end capping process is determined by the specific tropomyosin isoform decorating the actin filament.40,41
A Framework for Cell Migration
Specialized actin-based structures create a framework for migrating cells that generates contractile force required for pushing and pulling through complex extracellular environments and regulates cell-cell and cell-extracellular matrix adhesion. Early studies of migrating cells suggested that tropomyosins may be restricted to decorating stable actin filaments located behind the lamellipodia42,43 in the lamella region (∼2–15 µm behind the cells leading edge).44 Microinjection of skeletal muscle aTm into non-muscle cells inhibited lamellipodium formation due to increased stabilization of the actin filaments and exclusion of Arp2/3 and ADF/cofilin from the leading edge. Myosin II activity was significantly increased in the injected cells and both the rate of migration and persistence were increased. Based on these studies, it has been supposed that lack of tropomyosin localization to the leading edge of migrating cells may be important to the characteristic organization of actin at the leading edge (i.e., highly dynamic and branched). However, other studies have suggested that LMW tropomyosin isoforms are detectable in the ruffles of chicken embryo fibroblasts and human bladder carcinoma cells45 and, furthermore, immunohistochemical analysis suggested that both LMW and HMW tropomyosin are present at the leading edge, with LMW isoforms being more concentrated in this region.46 Possibly these discrepant findings may reflect cell-type specific patterns. However, the fact that tropomyosins have been detected at the leading edge of at least some cell types means that we must be cautious in applying a model where a tropomyosin-free compartment at the leading edge of a migrating cell promotes actin dynamics and membrane protrusion. Rather, based on the currently available data, we might envisage a model where restricted targeting of certain isoforms to the leading edge is permissive for the actin dynamics that are involved in membrane ruffling at the leading edge of migrating cells.
Studies of circulating erythrocytes have shown that at the cell membrane LMW tropomyosin from the TMP3 gene and Tm5a from the TMP1 gene form complexes with short actin filaments (∼35 nm) which are capped by tropomodulin. These short filaments link together a hexagonal lattice of spectrin, providing a membrane that can withstand the stress and strain of migration throughout the circulatory system.47 However, due to concentrated research efforts in the area of cancer cell migration and invasion that underpins metastatic progression, much of our current knowledge of tropomyosins in migration and invasion has come from investigations of tumor and cancer cell biology. Tumor profiling reveals consistent suppression of HMW tropomyosins during malignant transformation (reviewed in ref. 48). In particular, the HMW isoforms Tm1 and Tm2, from the TPM2 and TPM1 genes respectively, are frequently downregulated or lost.49–52 Both isoforms are predominantly associated with bundles of polymerized actin filaments, known as stress fibers. Current models based on cell migration on 2D surfaces suggest that stress fibers are critical both for the generation of force that allows cells to move forward and retraction of the trailing edge. Importantly, the use of 3D culture models and in vivo imaging of tagged actin,53 have similarly revealed the presence of stress fibers in vivo. Forced re-expression of Tm1 reverts cells to a non-transformed morphology, typically restoring anchorage dependent growth, stress fibers54–56 and decreasing proliferation.51 However, the power of Tm1 to revert transformed cells is not true for all cell types.57,58
It is currently unclear how Tm1 downregulation might be mechanistically associated with malignant progression and increased invasion and metastasis. One potential mechanism can be envisaged based on the fact that Tm1 restoration precipitates a significant change in integrin receptor expression profiles.52 Related to this, other tropomyosin isoforms have been reported to change the structure, number and dynamics of integrin-based focal adhesion structures.59,60 By changing integrin-based interactions with ECM proteins, the tropomyosins may thus impact cell migration and invasion. Moreover, one recent concept to arise is that the stabilization of actin filaments by certain tropomyosin isoforms blocks specific modes of cell invasion and motility.61 Speculatively, a certain plasticity of the actin filament system may be required for cell migration: loss of tropomyosin isoforms that contribute to actin filament stability may facilitate rearrangements of the actin cytoskeleton that are required for cell migration. Several reports suggest that tropomyosin isoforms have significantly different rates of association with actin filaments21,62 and such molecular level differences may be critical to how the particular isoform may subsequently influence filament dynamics.
Directing Traffic
Cell migration requires the delivery and recycling of molecules including integrin and growth factor receptors, matrix metalloproteases and a host of other signaling and structural molecules to the leading edge. While kinesin- and dynein-mediated transport along microtubules is a well-established trafficking mechanism, it is becoming increasingly clear that the actin filament system also operates as an important pathway for trafficking. For example, delivery of key regulators of cell migration such as Src kinase to integrin-based focal adhesions at the plasma membrane is an actin-dependent process.63 Importantly a series of studies provide evidence to support the notion that tropomyosins are involved in vesicle trafficking along actin filaments.64–68 While the specific role for tropomyosins in regulating trafficking required for cell migration and invasion is currently not known, the association between tropomyosin expression and integrin receptor expression profiles52 and focal adhesion structures59,60 raises the interesting question of whether the tropomyosins may be playing a role in actin-dependent vesicle trafficking in cell migration.
The Low Molecular Weight Tropomyosin Isoform Tm5NM1
Of all the cytoskeletal tropomyosin isoforms, the most studied to date in terms of a role in cell migration is the LMW Tropomyosin 5 non-muscle isoform 1 (Tm5NM1). Accumulating evidence has revealed that high-level Tm5NM1 expression inhibits cell migration and invasion, while conversely, loss of Tm5NM1 increases cell migration.28,59–61 An elevated level of Tm5NM1 expression promotes both myosin II recruitment and inhibition of ADF/cofilin activity which together result in stabilization and altered arrangement of the actin filaments (Fig. 2 and reviewed in ref. 69). Importantly, the effect of Tm5NM1 expression on ADF/cofilin activity is a dose-dependent effect.28 As the levels of Tm5NM1 are increased, more filaments are anticipated to be decorated with Tm5NM1 polymers. Based on the model that Tm5NM1 association blocks subsequent ADF/cofilin interaction with the actin filament (although it is currently not know how this leads to ADF/cofilin phosphorylation) there may be a feedback mechanism that then stimulates ADF/cofilin phosphorylation. Such differences in expression levels of Tm5NM1 reflect the range of endogenous Tm5NM1 expression seen across different tissues.70 Notably, some reports suggest that Tm5NM1 (and other LMW TPM3 isoforms) may be increased in some invasive cancer cells, with increased expression levels of 1.5–1.8-fold.71,72 However, others report either no change or slightly reduced expression of LMW TPM3 products in other transformed cell types.73
Figure 2.
Tm5NM1-mediated changes to the actin cytoskeleton. (A) B35 neuroblastoma control cells and expressing exogenous Tm5NM1, grown on fibronectin/laminin coated glass coverslips and stained with fluorescently-tagged phalloidin to detect filamentous actin. Arrows point to prominent dendritic actin network at the leading edge of control cells and the strong stress fibers visible in the Tm5NM1 cells. Scale bars 20 µm. (B) The same cells as in (A), but instead grown embedded in collagen gels to provide a 3-D environment. Cells were transfected with GFP-tagged Lifeact (a probe that detects filamentous actin). Arrows point to membrane protrusions in control cells and short spikes of filamentous actin in the Tm5NM1 cells. Shown are maximum projections of a confocal z-series, scale bars 10 µm.
There is a striking stabilization of focal adhesions concomitant with Tm5NM1-mediated stabilization of actin filaments.59 The precise mechanism by which Tm5NM1 decoration of actin filaments determines the dynamics of focal adhesions is still unknown.69 However, interesting recent data suggests that as actin filaments are bundled and polymerized at the cytoplasmic face of the focal adhesion74 there is isoform-specific recruitment of tropomyosins (Lappalainen P, personal communication). This new data suggests that rather than indirectly affecting the focal adhesion dynamics, the tropomyosins may play a direct role in determining the stability and lifetime of adhesions to the extracellular matrix; presumably this may extend to cell-cell adhesions.
Confirming the idea that tropomyosins may play a role in determining cell adhesion, we have recently shown that Tm5NM1 inhibits mesenchymal cell invasion,61 an invasion mode employed by cells as they negotiate a 3-D environment that is critically dependent on integrin-mediated adhesion to the extra-cellular matrix. This invasion mode is characterized by elongated cells that display branching polarized membrane protrusions in the direction of migration (Fig. 2 and reviewed in ref. 75). Critically, inhibition of mesenchymal invasion can cause some cells to switch to amoeboid invasion, characterized by amorphic morphology, non-apoptotic plasma membrane blebbing and abundant cortical actin.75 Rapid expansion and contraction of cortical actin allows amoeboid cells to squeeze through obstructing matrix and this is highly dependent on actomyosin contractility.76,77 Notably, Tm5NM1 inhibition of mesenchymal cell migration does not cause amoeboid transition.61 Given that Tm5NM1 induces non-muscle myosin II activation,28 it is intriguing that Tm5NM1 does not cause amoeboid transition and understanding this is likely to shed light on our understanding of amoeboid migration. Although the signaling mechanisms regulating mesenchymal to amoeboid transition are now being revealed,77 the contribution of actin dynamics in this process has been less clear. The lack of amoeboid transition induced by Tm5NM1 may suggest the role of Tm5NM1 in migration and invasion is separate to its effects on acto-myosin contractility. However, while acto-myosin contractility is required for focal adhesion maturation and stabilization, conversely, acto-myosin-dependent amoeboid invasion is characterized by reduced requirement for integrin-mediated interaction with the extra-cellular matrix. Thus, the key may lie in the stable focal adhesions induced by Tm5NM1, preventing amoeboid transition. The Tm5NM1 data highlight a critical role for a dynamic actin cytoskeleton in the switch between invasion modes and elucidation of this dynamic state may help identify new targets for treating metastatic cancer.
Conclusion
Studies of tropomyosins, in particular the investigation of their isoform-specific effects, are beginning to reveal new insights into how actin filament populations may be specified to perform discrete functions during cell migration. To date studies have focused on the role of one specific cytoskeletal isoform, Tm5NM1, in cell migration. Given the abundance of other tropomyosin isoforms available to decorate the actin filaments we anticipate that more members of this protein family will emerge as important coordinators of actin filament specialization during migration.
Acknowledgements
Our research is supported by grants from the National Health and Medical Research Council (G.O.), the NSW Cancer Council (G.O.) and the Ramaciotti Foundation (J.L.). C.B. is the recipient of an NHMRC post-graduate scholarship and a NSW Cancer Institute Scholar Award. We also gratefully acknowledge the generous support of Kaise Stephan and Channel Crossing for Life.
References
- 1.Laki K, Bowen WJ, Clark A. The polymerization of proteins; adenosine triphosphate and the polymerization of actin. J Gen Physiol. 1950;33:437–443. doi: 10.1085/jgp.33.5.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Stockem W, Weber K, Wehland J. The influence of microinjected phalloidin on locomotion, protoplasmic streaming and cytoplasmic organization in Amoeba proteus and Physarum polycephalum. Cytobiologie. 1978;18:114–131. [PubMed] [Google Scholar]
- 3.Liu H, Bretscher A. Characterization of TPM1 disrupted yeast cells indicates an involvement of tropomyosin in directed vesicular transport. J Cell Biol. 1992;118:285–299. doi: 10.1083/jcb.118.2.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sanger JW. Changing patterns of actin localization during cell division. Proc Natl Acad Sci USA. 1975;72:1913–1916. doi: 10.1073/pnas.72.5.1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Mills JC, Stone NL, Pittman RN. Extranuclear apoptosis. The role of the cytoplasm in the execution phase. J Cell Biol. 1999;146:703–708. doi: 10.1083/jcb.146.4.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Pollack R, Osborn M, Weber K. Patterns of organization of actin and myosin in normal and transformed cultured cells. Proc Natl Acad Sci USA. 1975;72:994–998. doi: 10.1073/pnas.72.3.994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Urban E, Jacob S, Nemethova M, Resch GP, Small JV. Electron tomography reveals unbranched networks of actin filaments in lamellipodia. Nat Cell Biol. 12:429–435. doi: 10.1038/ncb2044. [DOI] [PubMed] [Google Scholar]
- 8.Doyle AD, Wang FW, Matsumoto K, Yamada KM. One-dimensional topography underlies three-dimensional fibrillar cell migration. J Cell Biol. 2009;184:481–490. doi: 10.1083/jcb.200810041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gunning P, O'Neill G, Hardeman E. Tropomyosin-based regulation of the actin cytoskeleton in time and space. Physiol Rev. 2008;88:1–35. doi: 10.1152/physrev.00001.2007. [DOI] [PubMed] [Google Scholar]
- 10.Drees B, Brown C, Barrell BG, Bretscher A. Tropomyosin is essential in yeast, yet the TPM1 and TPM2 products perform distinct functions. J Cell Biol. 1995;128:383–392. doi: 10.1083/jcb.128.3.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Colote S, Widada JS, Ferraz C, Bonhomme F, Marti J, Liautard JP. Evolution of tropomyosin functional domains: differential splicing and genomic constraints. J Mol Evol. 1988;27:228–235. doi: 10.1007/BF02100079. [DOI] [PubMed] [Google Scholar]
- 12.MacLeod AR, Houlker C, Reinach FC, Smillie LB, Talbot K, Modi G, et al. A muscle-type tropomyosin in human fibroblasts: evidence for expression by an alternative RNA splicing mechanism. Proc Natl Acad Sci USA. 1985;82:7835–7839. doi: 10.1073/pnas.82.23.7835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Clayton L, Reinach FC, Chumbley GM, MacLeod AR. Organization of the hTMnm gene. Implications for the evolution of muscle and non-muscle tropomyosins. J Mol Biol. 1988;201:507–515. doi: 10.1016/0022-2836(88)90633-x. [DOI] [PubMed] [Google Scholar]
- 14.Hook J, Lemckert F, Qin H, Schevzov G, Gunning P. Gamma tropomyosin gene products are required for embryonic development. Mol Cell Biol. 2004;24:2318–2323. doi: 10.1128/MCB.24.6.2318-2323.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Smillie LB, Pato MD, Pearlstone JR, Mak AS. Periodicity of alpha-helical potential in tropomyosin sequence correlates with alternating actin binding sites. J Mol Biol. 1980;136:199–202. doi: 10.1016/0022-2836(80)90314-9. [DOI] [PubMed] [Google Scholar]
- 16.Smillie LB. Structure and functions of tropomyosins from muscle and non-muscle sources. Trends in Biochemical Sciences. 1979;4:151–155. [Google Scholar]
- 17.McLachlan AD, Stewart M, Smillie LB. Sequence repeats in alpha-tropomyosin. J Mol Biol. 1975;98:281–291. doi: 10.1016/s0022-2836(75)80118-5. [DOI] [PubMed] [Google Scholar]
- 18.Sodek J, Hodges RS, Smillie LB, Jurasek L. Amino-acid sequence of rabbit skeletal tropomyosin and its coiled-coil structure. Proc Natl Acad Sci USA. 1972;69:3800–3804. doi: 10.1073/pnas.69.12.3800. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gimona M, Watakabe A, Helfman DM. Specificity of dimer formation in tropomyosins: influence of alternatively spliced exons on homodimer and heterodimer assembly. Proc Natl Acad Sci USA. 1995;92:9776–9780. doi: 10.1073/pnas.92.21.9776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Muthuchamy M, Grupp IL, Grupp G, O'Toole BA, Kier AB, Boivin GP, et al. Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart. J Biol Chem. 1995;270:30593–30603. doi: 10.1074/jbc.270.51.30593. [DOI] [PubMed] [Google Scholar]
- 21.Temm-Grove CJ, Guo W, Helfman DM. Low molecular weight rat fibroblast tropomyosin 5 (TM-5): cDNA cloning, actin-binding, localization and coiled-coil interactions. Cell Motil Cytoskeleton. 1996;33:223–240. doi: 10.1002/(SICI)1097-0169(1996)33:3<223::AID-CM6>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
- 22.Bailey K. Tropomyosin; a new asymmetric protein component of the muscle fibril. Biochem J. 1948;43:271–279. doi: 10.1042/bj0430271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Spudich JA, Watt S. The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin. J Biol Chem. 1971;246:4866–4871. [PubMed] [Google Scholar]
- 24.Li XE, Lehman W, Fischer S. The relationship between curvature, flexibility and persistence length in the tropomyosin coiled-coil. J Struct Biol. 170:313–318. doi: 10.1016/j.jsb.2010.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.McKillop DF, Geeves MA. Regulation of the interaction between actin and myosin subfragment 1: evidence for three states of the thin filament. Biophys J. 1993;65:693–701. doi: 10.1016/S0006-3495(93)81110-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bernstein BW, Bamburg JR. Tropomyosin binding to F-actin protects the F-actin from disassembly by brain actin-depolymerizing factor (ADF) Cell Motil. 1982;2:1–8. doi: 10.1002/cm.970020102. [DOI] [PubMed] [Google Scholar]
- 27.Ono S, Ono K. Tropomyosin inhibits ADF/cofilin-dependent actin filament dynamics. J Cell Biol. 2002;156:1065–1076. doi: 10.1083/jcb.200110013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Bryce NS, Schevzov G, Ferguson V, Percival JM, Lin JJ, Matsumura F, et al. Specification of actin filament function and molecular composition by tropomyosin isoforms. Mol Biol Cell. 2003;14:1002–1016. doi: 10.1091/mbc.E02-04-0244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Bamburg JR. Proteins of the ADF/cofilin family: essential regulators of actin dynamics. Annu Rev Cell Dev Biol. 1999;15:185–230. doi: 10.1146/annurev.cellbio.15.1.185. [DOI] [PubMed] [Google Scholar]
- 30.Creed SJ, Desouza M, Bamburg JR, Gunning P, Stehn J. Tropomyosin isoform 3 promotes the formation of filopodia by regulating the recruitment of actin-binding proteins to actin filaments. Exp Cell Res. 2011;317:249–261. doi: 10.1016/j.yexcr.2010.10.019. [DOI] [PubMed] [Google Scholar]
- 31.Ishikawa R, Yamashiro S, Matsumura F. Differential modulation of actin-severing activity of gelsolin by multiple isoforms of cultured rat cell tropomyosin. Potentiation of protective ability of tropomyosins by 83 kDa nonmuscle caldesmon. J Biol Chem. 1989;264:7490–7497. [PubMed] [Google Scholar]
- 32.Ishikawa R, Yamashiro S, Matsumura F. Annealing of gelsolin-severed actin fragments by tropomyosin in the presence of Ca2+. Potentiation of the annealing process by caldesmon. J Biol Chem. 1989;264:16764–16770. [PubMed] [Google Scholar]
- 33.Blanchoin L, Pollard TD, Hitchcock-DeGregori SE. Inhibition of the Arp2/3 complex-nucleated actin polymerization and branch formation by tropomyosin. Curr Biol. 2001;11:1300–1304. doi: 10.1016/s0960-9822(01)00395-5. [DOI] [PubMed] [Google Scholar]
- 34.Bugyi B, Didry D, Carlier MF. How tropomyosin regulates lamellipodial actin-based motility: a combined biochemical and reconstituted motility approach. EMBO J. 2010;29:14–26. doi: 10.1038/emboj.2009.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Burgess DR, Broschat KO, Hayden JM. Tropomyosin distinguishes between the two actin-binding sites of villin and affects actin-binding properties of other brush border proteins. J Cell Biol. 1987;104:29–40. doi: 10.1083/jcb.104.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ishikawa R, Yamashiro S, Kohama K, Matsumura F. Regulation of actin binding and actin bundling activities of fascin by caldesmon coupled with tropomyosin. J Biol Chem. 1998;273:26991–26997. doi: 10.1074/jbc.273.41.26991. [DOI] [PubMed] [Google Scholar]
- 37.Skau CT, Kovar DR. Fimbrin and tropomyosin competition regulates endocytosis and cytokinesis kinetics in fission yeast. Curr Biol. 2010;20:1415–1422. doi: 10.1016/j.cub.2010.06.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Creed SJ, Bryce N, Naumanen P, Weinberger R, Lappalainen P, Stehn J, et al. Tropomyosin isoforms define distinct microfilament populations with different drug susceptibility. Eur J Cell Biol. 2008;87:709–720. doi: 10.1016/j.ejcb.2008.03.004. [DOI] [PubMed] [Google Scholar]
- 39.Greenfield NJ, Kostyukova AS, Hitchcock-DeGregori SE. Structure and tropomyosin binding properties of the N-terminal capping domain of tropomodulin 1. Biophys J. 2005;88:372–383. doi: 10.1529/biophysj.104.051128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Kostyukova AS, Choy A, Rapp BA. Tropomodulin binds two tropomyosins: a novel model for actin filament capping. Biochemistry. 2006;45:12068–12075. doi: 10.1021/bi060899i. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kostyukova AS. Capping complex formation at the slow-growing end of the actin filament. Biochemistry (Mosc) 2008;73:1467–1472. doi: 10.1134/s0006297908130075. [DOI] [PubMed] [Google Scholar]
- 42.DesMarais V, Ichetovkin I, Condeelis J, Hitchcock-DeGregori SE. Spatial regulation of actin dynamics: a tropomyosin-free, actin-rich compartment at the leading edge. J Cell Sci. 2002;115:4649–4660. doi: 10.1242/jcs.00147. [DOI] [PubMed] [Google Scholar]
- 43.Ponti A, Machacek M, Gupton SL, Waterman-Storer CM, Danuser G. Two distinct actin networks drive the protrusion of migrating cells. Science. 2004;305:1782–1786. doi: 10.1126/science.1100533. [DOI] [PubMed] [Google Scholar]
- 44.Gupton SL, Anderson KL, Kole TP, Fischer RS, Ponti A, Hitchcock-DeGregori SE, et al. Cell migration without a lamellipodium: translation of actin dynamics into cell movement mediated by tropomyosin. J Cell Biol. 2005;168:619–631. doi: 10.1083/jcb.200406063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Lin JJ, Hegmann TE, Lin JL. Differential localization of tropomyosin isoforms in cultured non-muscle cells. J Cell Biol. 1988;107:563–572. doi: 10.1083/jcb.107.2.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Hillberg L, Zhao Rathje LS, Nyakern-Meazza M, Helfand B, Goldman RD, Schutt CE, et al. Tropomyosins are present in lamellipodia of motile cells. Eur J Cell Biol. 2006;85:399–409. doi: 10.1016/j.ejcb.2005.12.005. [DOI] [PubMed] [Google Scholar]
- 47.Sung LA, Gao KM, Yee LJ, Temm-Grove CJ, Helfman DM, Lin JJ, et al. Tropomyosin isoform 5b is expressed in human erythrocytes: implications of tropomodulin-TM5 or tropomodulin-TM5b complexes in the protofilament and hexagonal organization of membrane skeletons. Blood. 2000;95:1473–1480. [PubMed] [Google Scholar]
- 48.Stehn JR, Schevzov G, O'Neill GM, Gunning PW. Specialisation of the tropomyosin composition of actin filaments provides new potential targets for chemotherapy. Curr Cancer Drug Targets. 2006;6:245–256. doi: 10.2174/156800906776842948. [DOI] [PubMed] [Google Scholar]
- 49.Cooper HL, Feuerstein N, Noda M, Bassin RH. Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes. Mol Cell Biol. 1985;5:972–983. doi: 10.1128/mcb.5.5.972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Varga AE, Stourman NV, Zheng Q, Safina AF, Quan L, Li X, et al. Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-beta. Oncogene. 2005;24:5043–5052. doi: 10.1038/sj.onc.1208688. [DOI] [PubMed] [Google Scholar]
- 51.Mahadev K, Raval G, Bharadwaj S, Willingham MC, Lange EM, Vonderhaar B, et al. Suppression of the transformed phenotype of breast cancer by tropomyosin-1. Exp Cell Res. 2002;279:40–51. doi: 10.1006/excr.2002.5583. [DOI] [PubMed] [Google Scholar]
- 52.Bharadwaj S, Thanawala R, Bon G, Falcioni R, Prasad GL. Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion. Oncogene. 2005;24:8291–8303. doi: 10.1038/sj.onc.1208993. [DOI] [PubMed] [Google Scholar]
- 53.Caspani EM, Echevarria D, Rottner K, Small JV. Live imaging of glioblastoma cells in brain tissue shows requirement of actin bundles for migration. Neuron Glia Biology. 2006:105–114. doi: 10.1017/S1740925X06000111. [DOI] [PubMed] [Google Scholar]
- 54.Prasad GL, Fuldner RA, Cooper HL. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci USA. 1993;90:7039–7043. doi: 10.1073/pnas.90.15.7039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, et al. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene. 2003;22:6194–6203. doi: 10.1038/sj.onc.1206719. [DOI] [PubMed] [Google Scholar]
- 56.Prasad GL, Masuelli L, Raj MH, Harindranath N. Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene. 1999;18:2027–2031. doi: 10.1038/sj.onc.1202264. [DOI] [PubMed] [Google Scholar]
- 57.Yager ML, Hughes JA, Lovicu FJ, Gunning PW, Weinberger RP, O'Neill GM. Functional analysis of the actin-binding protein, tropomyosin 1, in neuroblastoma. Br J Cancer. 2003;89:860–863. doi: 10.1038/sj.bjc.6601201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Shields JM, Mehta H, Pruitt K, Der CJ. Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin. Mol Cell Biol. 2002;22:2304–2317. doi: 10.1128/MCB.22.7.2304-2317.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Bach CT, Creed S, Zhong J, Mahmassani M, Schevzov G, Stehn J, et al. Tropomyosin isoform expression regulates the transition of adhesions to determine cell speed and direction. Mol Cell Biol. 2009;29:1506–1514. doi: 10.1128/MCB.00857-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Bach CT, Schevzov G, Bryce NS, Gunning PW, O'Neill GM. Tropomyosin isoform modulation of focal adhesion structure and cell migration. Cell Adh Migr. 2010;4:226–234. doi: 10.4161/cam.4.2.10888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Lees JL, Bach CTT, Bradbury P, Paul A, Gunning PW, O'Neill GM. The actin-associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility. Oncogene. 2010 doi: 10.1038/onc.2010.516. In press. [DOI] [PubMed] [Google Scholar]
- 62.Martin C, Schevzov G, Gunning P. Alternatively spliced N-terminal exons in tropomyosin isoforms do not act as autonomous targeting signals. J Struct Biol. 2010;170:286–293. doi: 10.1016/j.jsb.2009.12.016. [DOI] [PubMed] [Google Scholar]
- 63.Sandilands E, Cans C, Fincham VJ, Brunton VG, Mellor H, Prendergast GC, et al. RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane. Dev Cell. 2004;7:855–869. doi: 10.1016/j.devcel.2004.09.019. [DOI] [PubMed] [Google Scholar]
- 64.Stark BC, Sladewski TE, Pollard LW, Lord M. Tropomyosin and myosin-II cellular levels promote actomyosin ring assembly in fission yeast. Mol Biol Cell. 2010;21:989–1000. doi: 10.1091/mbc.E09-10-0852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Fanning AS, Wolenski JS, Mooseker MS, Izant JG. Differential regulation of skeletal muscle myosin-II and brush border myosin-I enzymology and mechanochemistry by bacterially produced tropomyosin isoforms. Cell Motil Cytoskeleton. 1994;29:29–45. doi: 10.1002/cm.970290104. [DOI] [PubMed] [Google Scholar]
- 66.Tang N, Ostap EM. Motor domain-dependent localization of myo1b (myr-1) Curr Biol. 2001;11:1131–1135. doi: 10.1016/s0960-9822(01)00320-7. [DOI] [PubMed] [Google Scholar]
- 67.Clayton JE, Sammons MR, Stark BC, Hodges AR, Lord M. Differential regulation of unconventional fission yeast myosins via the actin track. Curr Biol. 2010;20:1423–1431. doi: 10.1016/j.cub.2010.07.026. [DOI] [PubMed] [Google Scholar]
- 68.Hegmann TE, Lin JL, Lin JJ. Probing the role of non-muscle tropomyosin isoforms in intracellular granule movement by microinjection of monoclonal antibodies. J Cell Biol. 1989;109:1141–1152. doi: 10.1083/jcb.109.3.1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.O'Neill GM. The coordination between actin filaments and adhesion in mesenchymal migration. Cell Adh Migr. 2009;3:355–357. doi: 10.4161/cam.3.4.9468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Schevzov G, Vrhovski B, Bryce NS, Elmir S, Qiu MR, O'Neill GM, et al. Tissue-specific tropomyosin isoform composition. J Histochem Cytochem. 2005;53:557–570. doi: 10.1369/jhc.4A6505.2005. [DOI] [PubMed] [Google Scholar]
- 71.Miyado K, Kimura M, Taniguchi S. Decreased expression of a single tropomyosin isoform, TM5/TM30 nm, results in reduction in motility of highly metastatic B16-F10 mouse melanoma cells. Biochem Biophys Res Commun. 1996;225:427–435. doi: 10.1006/bbrc.1996.1190. [DOI] [PubMed] [Google Scholar]
- 72.Miyado K, Sato M, Taniguchi S. Transformation-related expression of a low-molecular-mass tropomyosin isoform TM5/TM30 nm in transformed rat fibroblastic cell lines. J Cancer Res Clin Oncol. 1997;123:331–336. doi: 10.1007/BF01438309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Novy RE, Lin JL, Lin CS, Lin JJ. Human fibroblast tropomyosin isoforms: characterization of cDNA clones and analysis of tropomyosin isoform expression in human tissues and in normal and transformed cells. Cell Motil Cytoskeleton. 1993;25:267–281. doi: 10.1002/cm.970250307. [DOI] [PubMed] [Google Scholar]
- 74.Hotulainen P, Lappalainen P. Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. J Cell Biol. 2006;173:383–394. doi: 10.1083/jcb.200511093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003;3:362–374. doi: 10.1038/nrc1075. [DOI] [PubMed] [Google Scholar]
- 76.Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol. 2010;188:11–19. doi: 10.1083/jcb.200909003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell. 2008;135:510–523. doi: 10.1016/j.cell.2008.09.043. [DOI] [PubMed] [Google Scholar]